Department of Dermatology Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Biostatistics & Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Arch Dermatol Res. 2023 Sep;315(7):2075-2078. doi: 10.1007/s00403-023-02601-w. Epub 2023 Mar 18.
Striae alba, as an unsettling skin complication, has the potential to threaten the physical appearance and psychological health of individuals. So far, dermatologists' endeavors have been futile in finding an ideal treatment. This study evaluated microneedling as a novel treatment modality for striae alba scars. Microneedling was implemented in 1-3 sessions in 2-week intervals among patients with striae alba lesions. The lesions were photographed before and 3 months after the treatment, while all side effects were recorded. Two non-involved dermatologists and a patient self-report based on a visual analog score scale were utilized to evaluate the clinical improvement of striae scars. The complication rate among the 32 patients was 25%, which consisted of seven (21.9%) cases of post-inflammatory hyperpigmentation and one case (3.1%) of skin infection. The average improvement score among the patients in our study based on their self-report was 5.3 ± 1.3. (Range 4-8), while based on physician evaluation was 5.6 ± 1.2 (range 3.5-8). There was a significant association between lower age and higher self-report scores. Also, the improvement of lesions was more significant in skin type 3 compared to 2, based on physician assessment. In this study, MN was effective in ameliorating SA scars and was observed to induce better clinical satisfaction in younger patients and breast lesions. The studies concerning the use of MN in treating SA have yielded much attention lately, and they have denoted the relatively low cost of MN, its capability to be utilized over vast treatment areas, and its safety in that regard. Further research regarding the comparison of MN's efficacy in solo use versus implementing it as an adjuvant modality should be carried out.
摘要:目的:评估微针治疗萎缩纹的疗效。方法:对 32 例萎缩纹患者进行微针治疗,每 2 周治疗 1-3 次,共 1-3 次。在治疗前和治疗后 3 个月对皮损进行拍照,并记录所有不良反应。采用两位非受累皮肤科医生和患者基于视觉模拟评分量表的自我报告评估来评估萎缩纹的临床改善情况。结果:32 例患者中有 25%出现并发症,包括 7 例(21.9%)炎症后色素沉着过度和 1 例(3.1%)皮肤感染。根据患者自我报告,平均改善评分为 5.3±1.3(范围 4-8),根据医生评估为 5.6±1.2(范围 3.5-8)。患者年龄越低,自我报告评分越高。此外,根据医生评估,3 型皮肤的病变改善比 2 型更显著。结论:微针对萎缩纹疤痕有效,且在年轻患者和乳房病变中观察到更好的临床满意度。最近,关于微针治疗萎缩纹的研究引起了广泛关注,其相对较低的成本、能够在大面积治疗区域使用以及安全性等特点使其成为一种有吸引力的治疗选择。未来应开展关于微针单独使用与作为辅助治疗方式的疗效比较的研究。
关键词:萎缩纹;微针;疗效;自我报告;